Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1996
12/05/1996CA2222147A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996CA2222099A1 1h-4(5)-substituted imidazole derivatives
12/05/1996CA2220955A1 A novel human purinergic p2u receptor
12/05/1996CA2219452A1 Method for preventing intervention-associated stenosis following non-bypass invasive interventions
12/05/1996CA2218253A1 Isothiazolones
12/04/1996EP0745584A1 Arylalkyl(thio) carboxamides compounds with affinity for melatonine receptors, processes for their preparation and pharmaceutical compositions containing them
12/04/1996EP0745384A2 Methods for inhibiting vascular smooth muscle cell migration
12/04/1996EP0745092A1 Peptide inhibitors of urokinase receptor activity
12/04/1996EP0745086A1 Tricyclic spiropiperidines
12/04/1996EP0745081A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
12/04/1996EP0745080A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
12/04/1996EP0745070A1 Pharmaceutical piperazine compounds
12/04/1996EP0744952A1 Method for treating vascular obstructions caused by abnormal cells
12/04/1996EP0744950A1 Agent for prophylaxis and treatment of thromboxane a 2?-mediated diseases
12/04/1996EP0744946A1 Compositions containing micronized nebivolol
12/04/1996EP0440738B1 Treatment of hypertension
12/04/1996CN1137269A Short-acting dihydropyridines
12/04/1996CN1137268A Amidino derivatives useful as nitric oxide synthase inhibitors
12/04/1996CN1137040A New mercaptoalanoyldipeptide compounds process for their preparation and pharmaceutical compositions containign them
12/04/1996CN1137036A Benzonitriles and benzofluorides
12/04/1996CN1137035A Basic group substituted benzoyl guanidine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same
12/04/1996CN1136960A Polyamines and polypeptides useful as antagonisis of excitatory amino acid neurotransmitiers and/or as blockers of calcium channels
12/04/1996CN1136920A Use of benzopyran derivatives for production of pharmaceutical compositions
12/04/1996CN1033454C Process for preparing 4-|(2-benzothiazolyl) methylamino¨-alpha-|(3,4-difluorophinoxy) methyl¨-1-piperidineethanol
12/03/1996US5580893 Treatment and prevention of angina pectoris; side-effect reduction; vasodilation
12/03/1996US5580892 Antidiarrhetic, antispastic, antiepileptic agents; diuretics
12/03/1996US5580885 5-HT4 receptor antagonists
12/03/1996US5580881 1,2,3,5,6,7,8,8a-Octahydro-5,5,8a-trimethyl-(8aβ)-6-isoquinolineamine derivatives, preparation method therefor and therapeutical use thereof
12/03/1996US5580867 Myocardial protection during ischemia and reperfusion
12/03/1996US5580576 Pharmaceutically/storage-stable nicorandil formulations
12/03/1996US5580555 Administering tumor necrosis factor and irradiating with low energy laser
12/03/1996US5580554 Methods of treating preeclampsia
11/1996
11/28/1996WO1996037626A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
11/28/1996WO1996037608A1 Novel variants of apolipoprotein a-i
11/28/1996WO1996037500A1 Novel quinoxaline dione derivatives, their production and their use in medicaments
11/28/1996WO1996037492A1 Isoxazoline and isoxazole derivatives as integrin receptor antagonists
11/28/1996WO1996037489A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996WO1996037482A1 Improved isoxazoline fibrinogen receptor antagonists
11/28/1996WO1996037456A1 New catechol derivatives
11/28/1996WO1996037223A1 Muscle trophic factor
11/28/1996WO1996037216A1 Method of administration of igf-i
11/28/1996WO1996037199A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
11/28/1996WO1996029065A3 Aminotetralin derivative for the therapy of cardiovascular diseases
11/28/1996DE19519979A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments
11/28/1996CA2222050A1 Improved isoxazoline fibrinogen receptor antagonists
11/28/1996CA2222041A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996CA2221980A1 Isoxazoline and isoxazole derivatives as integrin receptor antagonists
11/28/1996CA2221695A1 New quinoxalinedione derivatives, their production and use in pharmaceutical agents
11/28/1996CA2221458A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
11/28/1996CA2218759A1 Novel variants of apolipoprotein a-i
11/28/1996CA2218018A1 Method of administration of igf-i
11/27/1996EP0744397A2 Fluorophenyl substituted alkenyl carboxylic acid guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agent as well as a medicament containing them
11/27/1996EP0743953A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
11/27/1996EP0743951A1 Substituted lactose derivatives as cell adhesion inhibitors
11/27/1996EP0743944A1 Azacyclic derivatives
11/27/1996EP0743943A1 Pyridyl imidazole derivatives and processes for the preparation thereof
11/27/1996EP0743939A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
11/27/1996EP0743855A1 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
11/27/1996EP0743853A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
11/27/1996EP0621895A4 Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway.
11/27/1996CN1136811A Novel(R)-5-carbamyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyranes
11/27/1996CN1136810A 5-arylisoxazol-4-yl-substituted 2-aminocarboxylic acid compounds
11/27/1996CN1136808A Pseudodipeptide product having imidazole grouping and applications
11/27/1996CN1136774A Pharmaceutical emulsion
11/27/1996CN1136567A Dioxide pyrrolo-pyrrolo derivatives
11/27/1996CN1136566A Indole derivatives
11/27/1996CN1136565A Indole derivatives
11/27/1996CN1136562A Estrogen excitant/antagonist
11/27/1996CN1136556A Aromatic group substituted W-amino alkyl amide and alkyl amide
11/27/1996CN1136451A Piles curing liquid
11/27/1996CN1136432A Indole derivatives
11/26/1996US5578639 PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
11/26/1996US5578634 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors
11/26/1996US5578618 Treatment of vision defects
11/26/1996US5578617 Method and compositions for treating age related disorders
11/26/1996US5578616 Antiinflammatory agents, antiallergens, treatment for gastrointestinal and cardiovascular disorders
11/26/1996US5578612 Indole derivatives
11/26/1996US5578607 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
11/26/1996US5578575 Septic shock
11/26/1996CA2078287C Nitroxides as protectors against oxidative stress
11/21/1996WO1996036642A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996WO1996036639A1 Amidine derivatives useful as anti-platelet aggregation inhibitors and vasodilators
11/21/1996WO1996036620A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996WO1996036318A2 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
11/21/1996WO1996036227A1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase
11/21/1996WO1996030042A3 Methods of treating inflammation and compositions therefor
11/21/1996WO1996029407A3 Cellubrevin homologs
11/21/1996CA2221380A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996CA2220549A1 Amidine derivatives useful as anti-platelet aggregation inhibitors and vasodilators
11/21/1996CA2219487A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996CA2194692A1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase
11/20/1996EP0743319A1 Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ace and nep
11/20/1996EP0743304A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones
11/20/1996EP0743301A2 Benzoylguanidines containing fluorine
11/20/1996EP0639191B1 Indazol-3-one-2-yl derivatives of benzopyrans
11/20/1996CN1136316A Biologically active silicon compounds and their therapeutic and cosmetic applications
11/20/1996CN1136315A Method for preparing concentrated biologically active silicon compounds
11/20/1996CN1136312A Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
11/20/1996CN1136311A Novel benzenesulfonylimine derivatives as inhibitors of IL-1 action
11/20/1996CN1136281A Arteriosclerosis remedy
1 ... 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 ... 1595